Skip to content

Organogenesis Holdings Inc. ORGO Change in Other Liabilities

Change in Other Liabilities at other companies

IAR
Integra LifeSciencesIART
$369K-73.4%
MiMedx Group logo
MiMedx GroupMDXG
$250K+57.2%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$5.22M+75.6%
Axogen logo
AxogenAXGN
-$1K-102%
Vericel logo
VericelVCEL
$4K-99.6%
Medline, Inc.
 logo
Medline, Inc. MDLN
-$32M-256%

Other financials

Income statement

See full
Revenue$37.2M-57.1%
Gross profit$63.0M-22.5%
Operating income-$68.9M-158%
Net income-$53.2M-182%
EPS (diluted)-$0.44-159%

Balance sheet

See full
Cash & equivalents$91.4M-16.9%
Total debt$39.4M+24.8%
Total equity$244.6M+0.7%
Total assets$520.0M+11.3%

Cash flow

See full
Operating cash flow$21.1M+206%
CapEx$3.1M-13.2%
Free cash flow$18.0M+176%

Valuation

See full
Market cap$312.68M-23.7%
Enterprise value$260.72M-21.3%
P/E115×
P/S0.6×-0.3×

Profitability

See full
Gross margin75.9%+0.8pp
Operating margin0.5%
Net margin0.5%+0.3pp
FCF margin6.9%

Returns & leverage

See full
Return on equity1.1%+0.6pp
Debt / equity0.2×0.0×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Organogenesis Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.

The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organogenesis Holdings Inc.'s change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organogenesis Holdings Inc.'s change in other liabilities?
Organogenesis Holdings Inc. (ORGO) reported change in other liabilities of $293K in Q1 2026.
What is the long-term trend for Organogenesis Holdings Inc.'s change in other liabilities?
Over 3 years (2021 to 2024), Organogenesis Holdings Inc.'s change in other liabilities has grown at a -44.1% compound annual growth rate (CAGR), from -$6.07M to -$1.06M.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.